FROM ALGORITHMS TO EVIDENCE: ASSESSING ARTIFICIAL INTELLIGENCE CHATBOTS AND DRUG DATABASES FOR DETECTING CARDIO-DIABETIC DRUG INTERACTIONS

0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Objective: Electronic drug information resources are widely accessible and commonly used by healthcare professionals for identifying drug-drug interactions (DDIs). With the rapid advancements in artificial intelligence (AI), AI-powered chatbots have demonstrated their potential in detecting DDIs. However, variations exist in the scope, completeness, and consistency of information provided by different resources. This study aims to conduct a comparative evaluation of drug interaction databases and AI chatbots to assess their reliability in DDI identification. Methods: A total of three databases, namely Lexicomp, Drugs.com, DrugBank and AI-powered chatbots such as ChatGPT, Copilot and Gemini were used for comparative evaluation. The percentage of interactions that had an entry in each drug information resource was used to score each resource for scope. For each resource that described clinical effects, severity, mechanism, clinical management, and risk factors, a completeness score was calculated. The consistency of the information was assessed using the Fleiss' Kappa (κ) score, estimated with the Statistical Package for the Social Sciences (SPSS), version 29.0 (IBM, USA). Results: A total of 150 drug pairs were selected in the present study. The scope score was highest (100%) for Lexicomp, ChatGPT and Gemini. The completeness score was highest (100%) in all the AI-powered chatbots, followed by Drugs.com (90%) and Lexicomp (85.2%). Fleiss' kappa coefficient was used to determine the inter-resource agreement on DDI severity classification and the overall agreement was categorized as fair (κ=0.28, p<0.001). Cohen’s kappa coefficients were calculated to evaluate pairwise agreement among the resources and the overall mean kappa coefficient (κ=0.51, p<0.01) indicated a moderate level of agreement among the resources. Conclusion: Significant differences amongst the resources were observed in terms of severity classification. Using Lexicomp as reference, accuracy assessment was done and variable sensitivity, specificity, and predictive values among resources were observed. A moderate overall agreement in the inter-resource agreement on DDI presence-absence, with traditional databases showed stronger pairwise agreement than AI chatbots.

Cite

CITATION STYLE

APA

Alam, A., Saran, A., Joshi, R., Sridhar, S. B., Sharma, S., & Paliwal, S. (2025). FROM ALGORITHMS TO EVIDENCE: ASSESSING ARTIFICIAL INTELLIGENCE CHATBOTS AND DRUG DATABASES FOR DETECTING CARDIO-DIABETIC DRUG INTERACTIONS. International Journal of Applied Pharmaceutics, 17(5), 253–262. https://doi.org/10.22159/ijap.2025v17i5.54398

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free